You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 2, February 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Treatment of Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma With Intralesional Injection of Interferon Alfa-2b

Arch Ophthalmol. 2000;118:284-285.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas are typically localized, low-grade tumors that differ histologically from other forms of primary extranodal non-Hodgkin lymphomas. Patients with conjunctival MALT lymphoma have been cared for with radiation, chemotherapy, surgical excision, cryotherapy, and even observation alone. To our knowledge, this is only the third report of conjunctival MALT lymphoma treated with local injection of interferon alfa-2b (IFN-{alpha}-2b)1-2 and the first to appear in the North American ophthalmic literature.

Report of a Case

A 21-year-old male student had a 2-month history of a painless, progressively enlarging mass on his right eye. Findings from anterior segment examination revealed a large salmon-colored lesion involving the right nasal conjunctiva, caruncle, and superior and inferior fornices (Figure 1). His uncorrected visual acuity was 20/20 OU and findings from the remainder of the ocular examination were unremarkable. The patient was tentatively diagnosed as having a conjunctival lymphoid neoplasm, pending biopsy and orbital . . . [Full Text of this Article]


Comment
Kevin R. Lachapelle, MD; Rajinder Rathee, MD; Vladimir Kratky, MD; David F. Dexter, MD
Kingston, Ontario

Corresponding author: Kevin Lachapelle, MD, Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada K7L 3N6.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
Ferreri et al.
Ann Oncol 2008;19:835-846.
ABSTRACT | FULL TEXT  

Interferon treatment of childhood conjunctival lymphoma
Lucas et al.
Br. J. Ophthalmol. 2003;87:1191-1191.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.